✦ LIBER ✦

47 A MULTICENTRIC, DOUBLE-BLIND, RANDOMISED- CONTROLLED TRIAL (RCT) OF HIGH DOSE URSODEOXYCHOLIC ACID IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH)

✍ Scribed by V. Ratziu; V. De Ledinghen; F. Oberti; P. Mathurin; C. Wartelle-Bladou; C. Renou; J. Spénard

Book ID: 117377058
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 49 KB
Volume: 50
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(09)60049-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T1013 A Multicentric, Double-Blind, Rand

T1013 A Multicentric, Double-Blind, Randomized Placebo-Controlled Trial of High Dose Ursodeoxycholic Acid in Patients with Non-Alcoholic Steatohepatitis (NASH)

✍ Ratziu, Vlad; De Ledinghen, Victor; Frederic, Oberti; Mathurin, Philippe; Bladou 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Effect of ascorbic acid in patients with

Effect of ascorbic acid in patients with Charcot–Marie–Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial

✍ Joëlle Micallef; Shahram Attarian; Odile Dubourg; Pierre-Marie Gonnaud; Jean-Yve 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 169 KB

Randomised clinical trial: a multicentre

Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease

✍ Y. Kinoshita; K. Ashida; M. Hongo; The Japan Rabeprazole Study Group for NERD 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

MP56-19 LONG TERM RESULTS OF A DOUBLE-BL

MP56-19 LONG TERM RESULTS OF A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL OF INTERFERON ALPHA-2B AND LOW DOSE BCG IN PATIENTS WITH HIGH RISK NON-MUSCLE-INVASIVE BLADDER CANCER

✍ Esuvaranathan, Kesavan; Tham, Sin Mun; Ravuru, Mohan; Kamaraj, Revathi; Ng, Tze 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 137 KB

The ACT-ONE trial, a multicentre, random

The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design

✍ Andrew J. Stewart Coats; Venkatesan Srinivasan; Jayaraman Surendran; Haritha Chi 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 177 KB